Paradigm Biocapital Advisors LP Seagen Inc. Transaction History

Paradigm Biocapital Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $551,061 - $877,102	-4,319 Reduced 1.51%	281,969 $57.1 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $33.6 Million - $39.8 Million	286,288 New	286,288 $36.8 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $12 Million - $15.9 Million	-100,687 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $14.4 Million - $19.2 Million	100,687 New	100,687 $15.6 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.